HPV相关口咽癌治疗后颈清扫作用下降
该回顾性队列研究纳入418例HPV阳性、淋巴结转移的口咽癌患者,均接受放化疗或加速放疗,采用延迟PET指导的颈部管理。仅4.5%患者接受治疗后颈清扫,5年局部区域无失败生存91.2%,总生存86.4%,结论认为该策略可降低颈清扫率而不影响疾病控制与生存。
要点
- 延迟PET指导的颈部管理使治疗后颈清扫率降至4.5%。
- 5年局部区域无失败生存91.2%,总生存86.4%。
- 未发现与颈清扫风险增加相关的变量。
核心结论
- 在规范放化疗的HPV阳性口咽癌大队列中,延迟PET指导的颈部管理使治疗后颈清扫率低于历史报道,且未损害疾病控制与生存。
研究设计与样本
- 回顾性队列研究,来自前瞻性更新的机构数据库,纳入2005年1月至2017年7月治疗的418例淋巴结阳性、无远处转移的HPV阳性口咽癌患者,随访至少18个月。
主要发现
- 所测试变量均与治疗后颈清扫风险增加无关。
- 5年局部区域无失败生存率为91.2%(95%CI 88.3-94.2)。
- 5年区域无失败生存率为93.4%(95%CI 90.8-96.0)。
- 5年总生存率为86.4%(95%CI 83.0-90.1),口咽癌特异性生存率为90.2%(95%CI 87.1-93.4)。
关键数值与推荐
- 放疗方案包括70 Gy/35次/每周5次同步顺铂或西妥昔单抗,或加速放疗 alone 68 Gy/34次/每周6次。
临床怎么用
- 对HPV阳性口咽癌放化疗后颈部可检测淋巴结,采用延迟PET指导的管理可安全避免多数治疗后颈清扫。
局限性
- 回顾性研究设计,来自单机构数据库,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Human papillomavirus-associated oropharyngeal cancer (HPV+ OPC) with regional lymph node metastases has a good prognosis following (chemo)radiation therapy (C/RT) but lymph nodes may remain detectable for several months. Delayed [18F]-Fluorodeoxyglucose positron emission tomography/computed tomography (PET) can identify patients who may avoid post-treatment neck dissection (PTND). We investigated the rate of PTND in HPV+ OPC treated with C/RT and delayed PET-directed management of the neck. MATERIALS AND METHODS: This is a retrospective cohort study from a prospectively updated institutional database. Eligible patients were treated between January 2005 and July 2017 with a minimum of 18 months follow up, had node-positive, non-distant metastatic HPV+ OPC and were treated with RT (70 Gy/35#/5 per week) with concurrent Cisplatin or Cetuximab, or accelerated RT alone (68 Gy/34#/6 per week). The primary endpoint was rate of PTND. Secondary endpoints were locoregional failure free survival (LRFFS), regional failure free survival (RFFS), distant metastatic failure free survival (DMFFS), overall survival (OS) and oropharyngeal cancer-specific survival (CSS). RESULTS: 418 patients were eligible. Nineteen patients (4.5%) received a PTND. None of the tested variables were associated with an increased risk of PTND. Five-year probabilities for LRFFS, RFFS, DMFS, OS and CSS were, 91.2% (95% CI 88.3-94.2), 93.4% (95% CI 90.8-96.0), 91.2% (95% CI 88.3-94.2), 86.4% (95% CI 83.0-90.1) and 90.2% (95% CI 87.1-93.4), respectively. CONCLUSION: In a large cohort with good median follow up and protocolized C/RT, delayed PET-directed management of the neck affords a lower rate of PTND than reported in historical series without compromising disease control and survival.
引用
- Daniels CP, Liu HY, Bernard A, et al. The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer. Radiother Oncol. 2020. PMID: 32798595. doi:10.1016/j.radonc.2020.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。